Safety, efficacy and pharmacokinetics of peginterferon alpha2a (40 kd) in children with chronic hepatitis C.
暂无分享,去创建一个
M. Narkewicz | K. Schwarz | S. Nash | P. Mohan | J. Gries | J. Molleston | S. Hu | Ka Wang
暂无分享,去创建一个
M. Narkewicz | K. Schwarz | S. Nash | P. Mohan | J. Gries | J. Molleston | S. Hu | Ka Wang